Recent Research
Former Deputy Director of Global Health
Global health policy, health and economic development, population and poverty, drug resistance policy, cost-effectiveness and economic impacts of non-communicable diseases in developing countries
Rachel Nugent was the deputy director of global health at the Center for Global Development from March 2007 to March 2011. Her research focused on funding for non-communicable diseases in developing countries and the effects of demographic changes on development. She led CGD’s Demographics and Development in the 21st Century Initiative, chaired the Drug Resistance Working Group and Initiative, and was co-chair of the Working Group on UNFPA’s Leadership Transition. Nugent left CGD in 2011 to be associate professor and director of the Disease Control Priorities Network at the University of Washington’s Department of Global Health.
New
Popular
Working Papers Other CGD Pubs Events Selected Works
-
The Center for Global Development Working Group on UNFPA’s Leadership
Transition urges the UNFPA to sharpen its focus in pursuing the Programme of
Action developed at the 1994 International Conference on Population and
Development.
-
The time is right to reinvigorate UNFPA. Seventeen years after the groundbreaking ICPD meeting, UNFPA needs to make itself the lead agency for population, sexual and reproductive health, and reproductive rights in the UN system, as well as be more visible externally.
-
Drug resistance, a neglected but increasingly urgent problem, receives some much-needed attention this week as the focus of this year’s World Health Day, also dubbed Antimicrobial Resistance Day, on Thursday, April 7. I invited Rachel Nugent, lead author of The Race Against Drug Resistance , a...
-
On Monday, November 1, 2010 the Center for Global Development was pleased to host, along with the Institute of Medicine, What’s on the Agenda? Assessing the UN Summit on Non-communicable Diseases, featuring presentations by Rachel Nugent, Deputy Director of Global Health, CGD and Derek Yach,...
-
Heart disease, high blood pressure, diabetes and cancers are usually considered diseases of the rich world, the result of too much food and too little exercise. But these serious diseases are already a huge problem in the developing world, accounting for about half of the burden of disease. Yet new...
-
Once rich-world woes, non-communicable diseases such as diabetes and cancer account for half the burden of disease in the developing world. Yet Rachel Nugent finds that barely 3 percent of aid and philanthropic spending on health addresses this neglected health crisis.
-
A short film tells the story of Khalifa, a nurse in Ghana who contracted typhoid. She takes one drug and then another—each more expensive than the last—but still she isn’t well. The film uses expert interviews and animation to explain why drug resistance threatens us all—and what we can do...
-
The world is rapidly losing the ability to fight disease because of an invisible adversary: drug resistance. Resistance is inevitable but human actions are hastening it. Without a global effort to ensure lasting effectiveness of treatment, drug resistance is poised to get worse fast, raising costs,...
-
In an increasingly interconnected world, drug resistance does not stop at a patient’s bedside—it threatens global health. The conclusions of the Center for Global Development’s Drug Resistance Working Group make clear the need for urgent action to address this growing crisis.
-
The Center for Global Development’s Drug Resistance Working Group urges pharmaceutical companies, governments, donors, global health institutions, health providers, and patients to collectively and immediately tackle this global health threat by implementing four key recommendations.
-
Once rich-world woes, non-communicable diseases such as diabetes and cancer account for half the burden of disease in the developing world. Yet Rachel Nugent finds that barely 3 percent of aid and philanthropic spending on health addresses this neglected health crisis.
-
In an increasingly interconnected world, drug resistance does not stop at a patient’s bedside—it threatens global health. The conclusions of the Center for Global Development’s Drug Resistance Working Group make clear the need for urgent action to address this growing crisis.
-
The time is right to reinvigorate UNFPA. Seventeen years after the groundbreaking ICPD meeting, UNFPA needs to make itself the lead agency for population, sexual and reproductive health, and reproductive rights in the UN system, as well as be more visible externally.
-
The Center for Global Development Working Group on UNFPA’s Leadership
Transition urges the UNFPA to sharpen its focus in pursuing the Programme of
Action developed at the 1994 International Conference on Population and
Development.
-
In this working paper, commissioned as part of CGD's Drug Resistance Working Group, Prashant Yadav analyzes how changes in supply-chain business practices could help fix the misaligned incentives that hinder worldwide access to high-quality medical goods.
-
The Center for Global Development’s Drug Resistance Working Group urges pharmaceutical companies, governments, donors, global health institutions, health providers, and patients to collectively and immediately tackle this global health threat by implementing four key recommendations.
-
In this video, Dr. Joel E. Cohen, renowned demographer and a student of global demographic trends for nearly 40 years, launched CGD population series with an overview of global demographic trends.
-
In this video, Johns Hopkins University senior adjunct professor Peter Heller and Center for Global Development senior fellow Vijaya Ramachandran give a lecture on the importance of infrastructure in developing countries.
-
Beginning in September 2008, the Center for Global Development is sponsoring a new look at "Demographics and Development in the 21st Century." The role of demographics promises to be fundamental in shaping the coming world. In this series, leading scholars explore how demographic changes may affect...
-
This is a presentation from CGD Deputy Director of Global Health Rachel Nugent's working group on drug resistance.
There are no related books.
-
Focus UNFPA: Four Recommendations for Action (brief)
- Apr 11, 2011
The Center for Global Development Working Group on UNFPA’s Leadership
Transition urges the UNFPA to sharpen its focus in pursuing the Programme of
Action developed at the 1994 International Conference on Population and
Development.
-
Focus UNFPA: Four Recommendations for Action
- Apr 11, 2011
The time is right to reinvigorate UNFPA. Seventeen years after the groundbreaking ICPD meeting, UNFPA needs to make itself the lead agency for population, sexual and reproductive health, and reproductive rights in the UN system, as well as be more visible externally.
-
The Race Against Drug Resistance (brief)
- Jun 14, 2010
The Center for Global Development’s Drug Resistance Working Group urges pharmaceutical companies, governments, donors, global health institutions, health providers, and patients to collectively and immediately tackle this global health threat by implementing four key recommendations.
-
The Race Against Drug Resistance
- Jun 14, 2010
In an increasingly interconnected world, drug resistance does not stop at a patient’s bedside—it threatens global health. The conclusions of the Center for Global Development’s Drug Resistance Working Group make clear the need for urgent action to address this growing crisis.
-
-
-
Global Leadership: Who Is Fighting Drug Resistance and How?
- Jun 16, 2010
The Global Health Council's Dateline 2010 Global Health Goals & Metrics Conference presents
Global Leadership: Who is Fighting Drug Resistance and How?
Moderator: Gail Cassell, Eli Lilly and Company, United States
Anthony Boni, USAID, on United States Donor Role in Combating...
-
The Race Against Drug Resistance
- Jun 15, 2010
The world is rapidly losing the ability to fight disease because of an invisible adversary: drug resistance. Resistance is inevitable but human actions are hastening it. Without a global effort to ensure lasting effectiveness of treatment, drug resistance is poised to get worse fast, raising costs,...
-
Drug Resistance: A Global Challenge to Disease Control and Eradication
- May 5, 2010
Drugs to treat bacterial infections, malaria, and viruses are losing efficacy to pathogen resistance. The past decade has seen significant investment in new tools like drugs and vaccines but relatively little maintenance of existing tools to protect them. Resistance has emerged to artemisinins,...
-
Bringing Methods to Scale: New Perspectives in the Changing World of TB
- Mar 24, 2010
This year's World TB Day marks the halfway point for the Global Plan to Stop TB. We must scale up efforts and continue to seek innovative ways to stop TB if we are to achieve our targets. Join us for a discussion of TB and drug-resistant TB, including the impact on global health and the current...
-
-
The Human Footprint on Climate
- Jun 23, 2009
As part of the "Demographics and Development in the 21st Century" series, CGD Senior Fellow David Wheeler will summarize the cross-country research he conducted with Dan Hammer on the economics of population policy for carbon emissions reduction. Wheeler includes assessments of the effects of...
-
Brain Drain or Gain: Examining International Migration
- May 6, 2009
Brain drain has long been seen in developing countries as an undesirable consequence of migration. This concern is amplified by the recent increase in skilled emigration as some developed countries orient their immigration policies to embrace higher-skilled workers. Economic theory suggests a...
-
Population, Poverty and Economic Development
- Apr 7, 2009
Economists, demographers and other social scientists have long debated the relationship between demographic change and economic outcomes. In recent years, general agreement has emerged to the effect that improving economic conditions for individuals generally lead to lower birth rates. But there is...
-
Grinnell College Symposium on Global Pharmaceuticals
- Feb 3, 2009
Speakers at a three-day symposium on global pharmaceuticals at Grinnell College, Feb. 3 to 5, will address issues of access, patents and development, the politics of clinical trials and public health policy affected by this international industry.
Sponsored by the Rosenfield Program in...
-
-
-
Beyond Population: Everybody Counts in Development
- Sep 23, 2008
Beginning in September 2008, the Center for Global Development is sponsoring a new look at "Demographics and Development in the 21st Century." The role of demographics promises to be fundamental in shaping the coming world. In this series, leading scholars explore how demographic changes may...
-
A Healthy U.S. Farm Policy in a Globalized World
- Sep 10, 2007
A healthy U.S. farm policy would reduce the negative effects of current policy on farmers in developing countries and do more to make healthy foods, such as fruits and vegetables, available to a world battling growing obesity problems. The farm bill passed by the U.S. House of Representatives in...
-
|
|
Print
Share
